Literature DB >> 26338823

Reply to the letter to the editor: genetic influence on visual outcomes of polypoidal choroidal vasculopathy.

Masayuki Hata1,2, Akitaka Tsujikawa3,4, Nagahisa Yoshimura1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26338823     DOI： 10.1007/s00417-015-3163-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.

Authors:  Adrian Koh; Won Ki Lee; Lee-Jen Chen; Shih-Jen Chen; Yehia Hashad; Hakyoung Kim; Timothy Y Lai; Stefan Pilz; Paisan Ruamviboonsuk; Erika Tokaji; Annemarie Weisberger; Tock H Lim
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

2.  Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.

Authors:  Masayuki Hata; Akitaka Tsujikawa; Masahiro Miyake; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Isao Nakata; Ayako Takahashi; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-30       Impact factor: 3.117

3.  Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography.

Authors:  Hiroshi Tamura; Akitaka Tsujikawa; Atsushi Otani; Norimoto Gotoh; Manabu Sasahara; Takanori Kameda; Daisuke Iwama; Yuko Yodoi; Michiko Mandai; Nagahisa Yoshimura
Journal:  Br J Ophthalmol       Date:  2007-02-21       Impact factor: 4.638

4.  A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes.

Authors:  Colin S H Tan; Wei Kiong Ngo; Louis W Lim; Tock Han Lim
Journal:  Br J Ophthalmol       Date:  2014-07-04       Impact factor: 4.638

5.  Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Yasuhiko Hirami; Akitaka Tsujikawa; Atsushi Otani; Yuko Yodoi; Hiroko Aikawa; Michiko Mandai; Nagahisa Yoshimura
Journal:  Retina       Date:  2007-03       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.